uniQure (QURE) Q3 FY2026 earnings: revenue $5 million, up 40.4% on the year

uniQure N.V. (QURE) reported revenue of $5 million for Q3 FY2026, the quarter ended 30 September 2026, up 40.4% on the same quarter a year earlier. Net income was -$61 million, and diluted earnings per share $-0.88. The figures are the company's own, from the 10-Q it filed with the SEC on 4 November 2026.

Revenue

$5 million

+40.4% on the year · -11.0% on the quarter

Q4 FY2024Q3 FY2026

Operating margin

-1019.6%

-1379.0% a year earlier

Q4 FY2024Q3 FY2026

Net income

-$61 million

Q4 FY2024Q3 FY2026

Diluted EPS

-$0.88

Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 4 new, 2 kept.

BLA accepted under accelerated approval: The FDA accepted the BLA for ifezuntirgene inilparvovec under the Accelerated Approval pathway and granted Priority Review, with a PDUFA target action date of May 1, 2027.
Primary cUHDRS result not significant: At 48 months in 12 high-dose patients, cUHDRS slowing of 44% versus the updated external control had p=0.144, which the company describes as non-significant.
TFC slowing at 48 months: TFC, the primary measure for the confirmatory study, showed a 61% slowing at 48 months, with a nominal p-value of 0.008.

Read the earnings call summary

Income statement (profit and loss)

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Revenue	5.2	5.8	3.7	-11.0%	+40.4%
Cost of revenue	0.2	0.3	0.4	-32.6%	-40.7%
Gross profit	5.0	5.5	3.3	-9.7%	+50.2%
Gross margin	95.5%	94.0%	89.2%
Research and development	35.5	34.0	34.4	+4.6%	+3.3%
Selling, general and administrative	23.9	17.4	19.4	+37.7%	+23.0%
Operating income	-53.0	-52.2	-51.0
Operating margin	-1019.6%	-893.7%	-1379.0%
Interest expense	14.6	14.4	16.7	+1.5%	-12.8%
Pre-tax income	-60.5	-79.2	-71.9
Income tax	0.7	1.8	8.6	-63.3%	-92.2%
Net income	-61.2	-81.1	-80.5
Net margin	-1178.2%	-1387.8%	-2175.9%
Diluted EPS	-$0.88	-$1.22	-$1.38

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Operating cash flow	-47.8	-28.6	-16.4
Capital expenditure	0.0	0.5	n/a	-97.7%
Free cash flow	-47.8	-29.0	n/a
Free cash flow margin	-920.7%	-497.3%	n/a
Cash from investing	-269	53.3	26.6
Cash from financing	1.6	249	332	-99.4%	-99.5%
Depreciation and amortisation	5.5	4.9	3.6	+11.1%	+50.1%
Share-based compensation	5.4	5.0	3.5	+8.6%	+54.6%
Diluted shares, weighted	70m	66m	59m	+5.5%	+19.5%
Shares outstanding at period end	70m	69m	62m	+1.0%	+12.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ million	Q3 FY2026	Q2 FY2026	Q3 FY2025	On the quarter	On the year
Shareholders' equity	295	324	229	-9.1%	+28.8%
Debt	50.3	50.1	51.9	+0.4%	-3.0%
Operating lease liabilities	9.0	9.7	10.4	-6.8%	-12.8%
Other liabilities	587	601	597	-2.4%	-1.8%
Total liabilities and equity	941	985	888	-4.5%	+5.9%
Fixed assets	9.9	11.4	15.4	-12.8%	-35.6%
Goodwill	24.5	24.6	25.3	-0.3%	-3.3%
Intangible assets	61.9	62.1	74.1	-0.4%	-16.6%
Securities held for sale or to maturity	670	n/a	n/a
Cash and equivalents	98.4	413	597	-76.2%	-83.5%
Receivables	4.8	5.8	n/a	-16.9%
Other assets	71.0	468	176	-84.8%	-59.7%
Total assets	941	985	888	-4.5%	+5.9%

Questions

What was uniQure's revenue in Q3 FY2026?

uniQure (QURE) reported revenue of $5 million for Q3 FY2026, the quarter ended 30 September 2026, up 40.4% on the same quarter a year earlier.

How much did uniQure earn in Q3 FY2026?

Net loss for Q3 FY2026 was $61 million, and the diluted loss per share $0.88.

When did uniQure report Q3 FY2026 results?

uniQure filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 4 November 2026.

Quarterly results, the last 20 quarters

	Q4 FY2021 *	Q1 FY2022	Q2 FY2022	Q3 FY2022	Q4 FY2022 *	Q1 FY2023	Q2 FY2023	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026	Q3 FY2026
Revenue	57.7	1.8	0.5	1.4	103	5.3	2.4	1.4	6.7	8.5	11.1	2.3	5.2	1.6	5.3	3.7	5.6	3.6	5.8	5.2
Cost of revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.1	0.2	0.3	0.6	0.2	0.7	0.4	0.4	0.2	0.3	0.2
Gross profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.3	10.9	2.0	4.6	1.4	4.6	3.3	5.1	3.3	5.5	5.0
Gross margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	98%	98%	88%	88%	87%	88%	89%	92%	94%	94%	95%
R&D	41.7	45.0	46.2	48.1	58.3	60.8	46.0	65.4	42.6	40.7	33.7	30.6	38.8	36.1	35.4	34.4	34.8	29.2	34.0	35.5
SG&A	14.6	11.0	12.5	13.3	18.3	17.8	21.2	18.1	17.5	13.9	15.8	11.6	11.4	10.9	13.5	19.4	21.6	20.1	17.4	23.9
Operating income	2.1	-54.1	-56.1	-59.5	26.5	-74.2	-65.1	-81.9	-61.7	-54.2	-44.0	-40.2	-45.8	-39.3	-43.9	-51.0	-51.1	-45.7	-52.2	-53.0
Operating margin	4%	-3018%	-11280%	-4108%	26%	-1393%	-2687%	-5819%	-923%	-639%	-396%	-1759%	-878%	-2510%	-834%	-1379%	-918%	-1284%	-894%	-1020%
Interest expense	2.1	2.5	2.7	3.1	3.4	3.6	6.8	15.4	15.7	16.1	16.2	16.6	14.9	15.1	15.6	16.7	14.6	14.0	14.4	14.6
Pre-tax income	7.9	-47.3	-39.4	-48.2	6.6	-78.4	-68.3	-89.6	-70.2	-65.0	-55.4	-44.4	-72.4	-43.1	-37.3	-71.9	-41.0	-53.0	-79.2	-60.5
Tax rate	-4%	n/a	n/a	n/a	-3%	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net income	8.2	-46.7	-39.1	-47.9	6.8	-77.2	-68.5	-89.6	-73.2	-65.6	-56.3	-44.4	-73.3	-43.6	-37.7	-80.5	-37.1	-53.5	-81.1	-61.2
Net margin	14%	-2605%	-7859%	-3303%	7%	-1450%	-2827%	-6366%	-1094%	-773%	-506%	-1940%	-1403%	-2785%	-717%	-2176%	-666%	-1503%	-1388%	-1178%
Diluted EPS	$0.23	-$1.00	-$0.84	-$1.02	$0.15	-$1.63	-$1.44	-$1.88	-$1.52	-$1.36	-$1.16	-$0.91	-$1.49	-$0.82	-$0.69	-$1.38	-$0.57	-$0.85	-$1.22	-$0.88
Operating cash flow	-47.1	-25.7	-15.7	-49.0	-54.7	-78.3	-57.0	38.9	-49.5	-60.6	-32.7	-36.6	-52.8	-44.1	-39.9	-16.4	-77.6	-38.2	-28.6	-47.8
Capital expenditure	3.6	4.1	4.6	4.0	5.1	2.3	1.1	1.7	2.0	2.3	0.6	0.4	0.0	0.1	0.3	n/a	0.1	0.1	0.5	0.0
Free cash flow	-50.6	-29.8	-20.3	-53.0	-59.7	-80.6	-58.1	37.2	-51.6	-62.9	-33.3	-37.0	-52.9	-44.2	-40.2	n/a	-77.7	-38.4	-29.0	-47.8
Shares outstanding	46m	47m	47m	47m	47m	48m	48m	48m	48m	48m	49m	49m	49m	55m	55m	62m	62m	63m	69m	70m
Filing	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 4 November 2026: the filing.